Annual General Meeting in ALK-Abelló A/S held on 13 March 2025

GlobeNewswire

2025/03/14

ALK (ALKB:DC / OMX: ALK B / AKBLF): ALK-Abelló A/S held its Annual General Meeting on 13 March 2025.

The Annual General Meeting transacted the following business:

Approval of the annual report 2024 and discharge of the Board of Directors and Board of Management
Resolution not to declare ordinary dividend in accordance with the approved annual report for 2024 and to allocate the profits in accordance with the approved annual report
Adoption of the remuneration report for 2024
Adoption of the remuneration to the Board of Directors for the present year
Re-election of Anders Hedegaard as the Chair of the Board of Directors
Re-election of Lene Skole as the Vice Chair of the Board of Directors
Re-election of Gitte Aabo, Lars Holmqvist, Jesper Høiland, Bertil Lindmark and Alan Main to the Board of Directors
PwC Statsautoriseret Revisionspartnerselskab was re-appointed as the company’s auditor in respect of statutory financial reporting as well as sustainability reporting

ALK-Abelló A/S

For further information please contact:

Anders Hedegaard, Chair, tel. +45 4574 7576

About ALK
ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,800 people worldwide and is listed on Nasdaq Copenhagen. Find more information at www.alk.net.

Attachment

Company release_06_25UK_130325_AGM minutes

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2519785273"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2519785273\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2519785273?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-14 01:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2519785273","market":"us","top_or_hot":-1,"title":"Annual General Meeting in ALK-Abelló A/S held on 13 March 2025","media":"GlobeNewswire","content":"<html><body><p>ALK (<i>ALKB:DC / OMX: ALK B / AKBLF</i>): ALK-Abelló A/S held its Annual General Meeting on 13 March 2025.</p> <p>The Annual General Meeting transacted the following business:</p> <ul><li>Approval of the annual report 2024 and discharge of the Board of Directors and Board of Management</li><li>Resolution not to declare ordinary dividend in accordance with the approved annual report for 2024 and to allocate the profits in accordance with the approved annual report</li><li>Adoption of the remuneration report for 2024</li><li>Adoption of the remuneration to the Board of Directors for the present year</li><li>Re-election of Anders Hedegaard as the Chair of the Board of Directors</li><li>Re-election of Lene Skole as the Vice Chair of the Board of Directors</li><li>Re-election of Gitte Aabo, Lars Holmqvist, Jesper Høiland, Bertil Lindmark and Alan Main to the Board of Directors</li><li>PwC Statsautoriseret Revisionspartnerselskab was re-appointed as the company’s auditor in respect of statutory financial reporting as well as sustainability reporting</li></ul> <p><b>ALK-Abelló A/S</b></p> <p><b>For further information please contact:</b></p> <p>Anders Hedegaard, Chair, tel. +45 4574 7576</p> <p><b><i>About ALK</i></b><br/><i>ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,800 people worldwide and is listed on Nasdaq Copenhagen. Find more information at www.alk.net</i><i>.</i></p> <p>\n<strong>Attachment</strong>\n</p>\n<ul>\n<li>\nCompany release_06_25UK_130325_AGM minutes\n</li>\n</ul>\n<br/><img referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml-eu.globenewswire.com/media/Nzc5YTRhMzgtNzU5ZS00YmZhLTk2NGUtZTVlY2Q1NWUyYzQ1LTEwMTM4MDQtMjAyNS0wMy0xMy1lbg==/tiny/ALK-Abello.png\"/></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Annual General Meeting in ALK-Abelló A/S held on 13 March 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAnnual General Meeting in ALK-Abelló A/S held on 13 March 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1016364462\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/31bb960c88eab45f27ccc9fce75dee9a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">GlobeNewswire </p>\n<p class=\"h-time\">2025-03-14 01:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>ALK (<i>ALKB:DC / OMX: ALK B / AKBLF</i>): ALK-Abelló A/S held its Annual General Meeting on 13 March 2025.</p> <p>The Annual General Meeting transacted the following business:</p> <ul><li>Approval of the annual report 2024 and discharge of the Board of Directors and Board of Management</li><li>Resolution not to declare ordinary dividend in accordance with the approved annual report for 2024 and to allocate the profits in accordance with the approved annual report</li><li>Adoption of the remuneration report for 2024</li><li>Adoption of the remuneration to the Board of Directors for the present year</li><li>Re-election of Anders Hedegaard as the Chair of the Board of Directors</li><li>Re-election of Lene Skole as the Vice Chair of the Board of Directors</li><li>Re-election of Gitte Aabo, Lars Holmqvist, Jesper Høiland, Bertil Lindmark and Alan Main to the Board of Directors</li><li>PwC Statsautoriseret Revisionspartnerselskab was re-appointed as the company’s auditor in respect of statutory financial reporting as well as sustainability reporting</li></ul> <p><b>ALK-Abelló A/S</b></p> <p><b>For further information please contact:</b></p> <p>Anders Hedegaard, Chair, tel. +45 4574 7576</p> <p><b><i>About ALK</i></b><br/><i>ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,800 people worldwide and is listed on Nasdaq Copenhagen. Find more information at www.alk.net</i><i>.</i></p> <p>\n<strong>Attachment</strong>\n</p>\n<ul>\n<li>\nCompany release_06_25UK_130325_AGM minutes\n</li>\n</ul>\n<br/><img referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml-eu.globenewswire.com/media/Nzc5YTRhMzgtNzU5ZS00YmZhLTk2NGUtZTVlY2Q1NWUyYzQ1LTEwMTM4MDQtMjAyNS0wMy0xMy1lbg==/tiny/ALK-Abello.png\"/></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4008","symbol_name":"航空公司","start_time":0,"source_url":"https://www.globenewswire.com/news-release/2025/03/13/3042490/0/en/Annual-General-Meeting-in-ALK-Abell%C3%B3-A-S-held-on-13-March-2025.html","article_id":"2519785273","we_media_id":"1016364462","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2519785273","pubTimestamp":1741885560,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"GlobeNewswire","introduction":"Share your news with media, investors, and consumers with targeted distribution options from one of the world’s largest and most trusted newswires.","home_visible":1,"id":"1016364462","head_image":"https://static.tigerbbs.com/31bb960c88eab45f27ccc9fce75dee9a"},"summary":"Attachment","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4008":"航空公司","BK4588":"碎股","BK4500":"航空公司","ALK":"阿拉斯加航空集团有限公司","BK4585":"ETF&股票定投概念"},"translate_title":"Alk-AbellóA/S于2025年3月13日举行的股东周年大会","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALK":1},"content_text":"ALK (ALKB:DC / OMX: ALK B / AKBLF): ALK-Abelló A/S held its Annual General Meeting on 13 March 2025. The Annual General Meeting transacted the following business: Approval of the annual report 2024 and discharge of the Board of Directors and Board of ManagementResolution not to declare ordinary dividend in accordance with the approved annual report for 2024 and to allocate the profits in accordance with the approved annual reportAdoption of the remuneration report for 2024Adoption of the remuneration to the Board of Directors for the present yearRe-election of Anders Hedegaard as the Chair of the Board of DirectorsRe-election of Lene Skole as the Vice Chair of the Board of DirectorsRe-election of Gitte Aabo, Lars Holmqvist, Jesper Høiland, Bertil Lindmark and Alan Main to the Board of DirectorsPwC Statsautoriseret Revisionspartnerselskab was re-appointed as the company’s auditor in respect of statutory financial reporting as well as sustainability reporting ALK-Abelló A/S For further information please contact: Anders Hedegaard, Chair, tel. +45 4574 7576 About ALKALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,800 people worldwide and is listed on Nasdaq Copenhagen. Find more information at www.alk.net. \nAttachment\n\n\n\nCompany release_06_25UK_130325_AGM minutes","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}